Director/PDMR Shareholding

RNS Number : 2641U

Hikma Pharmaceuticals Plc

21 November 2019

 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mohammed 'Ali' Al-Husry
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Mr. Al-Husry has a beneficial interest in DKYB Limited, which holds shares in Hikma.  DKYB Limited previously had 1,109,748 Hikma shares pledged to Citibank Switzerland.  On 19 November 2019 the pledge arrangement was changed so that 989,748 shares were pledged to Citibank Jersey and 120,000 shares were pledged to Citibank Switzerland.  Both Citibank Switzerland and Citibank Jersey are ultimately wholly owned by Citigroup Inc.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 0
d)	Aggregated information	Aggregated volume: 0 Price: £0.00p
e)	Date of the transaction	19 November 2019
f)	Place of the transaction	London

Peter Speirs, Company Secretary, Responsible for releasing this announcement

21 November 2019

 

END

 

 

DSHBSBDBLSDBGCB